Truvvo Partners’s Novo Nordisk NVO Stock Holding History

Truvvo Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-272,222	Closed	-$5.66M	–	128
2016 Q3	$5.66M	Buy	+272,222	New	+$6.75M	2.54%	9

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Truvvo Partners's NVO Position: Q4 2016 in Review

Truvvo Partners sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 272,222 shares — an estimated $5.66M sold.

Truvvo Partners first reported a position in NVO in Q3 2016 and held it in 1 quarter. The position peaked at $5.66M in Q3 2016. 482 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

Truvvo Partners reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
Truvvo Partners sold 272,222 Novo Nordisk shares in Q4 2016, an estimated $5.66M.
Truvvo Partners first reported a position in Novo Nordisk in Q3 2016 and held it in 1 quarter.
Truvvo Partners's Novo Nordisk position peaked at $5.66M in Q3 2016.
482 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on Truvvo Partners's 13F filing for Q4 2016, filed 13 Feb 2017.